georgia medical marijuana Archives

Georgia House Votes to Add PTSD and Intractable Pain to State’s Medical Marijuana Program

March 2, 2018

Georgia’s House of Representatives has overwhelmingly passed legislation to expand the state’s medical marijuana program.

The House approved House Bill 764 Wednesday in a 145 to 17 vote, sending it to the Senate for consideration. The measure would allow those with post traumatic stress disorder (PTSD) and intractable pain to join the state’s Low THC Oil Patient Registry. The registry, established in 2015, allows those with certain medical conditions to legally possess and use up to 20 ounces of low-THC cannabis oil .

If the bill is approved by the Senate, it will be sent to Governor Nathan Deal for consideration; Deal has expressed support for the measure, indicating he would likely sign it into law if given the chance. If the measure does become law, PTSD and intractable pain would join epilepsy, cancer, Parkinson’s disease, ALS, sickle cell anemia, multiple sclerosis, Crohn’s disease and mitochondrial disease as qualifying conditions.

Georgia Medical Marijuana Bill Signed Into Law by Governor

May 9, 2017May 8, 2017

Georgia’s governor has signed into law a measure that significantly expands the state’s limited medical marijuana law.

Governor Nathan Deal signed Senate Bill 16 into law today, roughly a month and a week after it was passed by the full legislature; it passed the Senate with a 45 to 6 vote, and was passed by the House of Representatives with a vote of 167 to 4 vote

The new law greatly expands the list of conditions that qualify an individual to legally use low-THC marijuana medicines (such as oils and tinctures) to include Tourette’s Syndrome, autism spectrum disorder, epidermolysis bullosa, Alzheimer’s disease, AIDS (when “such syndrome is diagnosed as severe or end stage”) and peripheral neuropathy.

Georgia Legislature Passes Medical Marijuana Bill, Sends it to Governor

March 30, 2017

Legislation significantly expanding Georgia’s medical marijuana law has been passed by the state’s full legislature.

The Senate passed Senate Bill 16 today with a 45 to 6 vote, just a couple days after it was passed by the House of Representatives with a 167 to 4 vote. It has now been sent to Governor Nathan Deal for consideration.

If signed into law by Governor Deal, or allowed to become law without his signature, it would expand the list of conditions that qualify an individual to legally use cannabis-based medicines to include Tourette’s Syndrome, autism spectrum disorder, epidermolysis bullosa, Alzheimer’s disease, AIDS (when “such syndrome is diagnosed as severe or end stage”) and peripheral neuropathy.

Georgia House Passes Medical Cannabis Expansion Measure with 167 to 4 Vote

March 28, 2017

Georgia’s full House of Representatives has voted to expand the state’s medical cannabis law.

Senate Bill 16 was passed by the House today with a 167 to 4 vote; the proposal has already been passed by the full Senate.

The proposed law would expand the list of conditions that qualify an individual to legally use cannabis-based medicines to include Tourette’s Syndrome, autism spectrum disorder, epidermolysis bullosa, Alzheimer’s disease, AIDS (when “such syndrome is diagnosed as severe or end stage”) and peripheral neuropathy.

These conditions would join cancer, ALS, multiple sclerosis, Crohn’s disease, mitochondrial disease, Parkinson’s disease and sickle cell disease as qualifying medical cannabis conditions.

Georgia Medical Marijuana Bill Passed by House Committee

March 17, 2017

A key House committee has given approval to a Georgia bill that would greatly expand the state’s medical marijuana program.

Senate Bill 16 would expand a 2015 law that allows for the medical use of cannabis oil by adding six new conditions that qualify someone to become a legal medical cannabis patient. Those conditions are AIDS, autism, Alzheimer’s disease, epidermolysis bullosa, Tourette’s syndrome and peripheral neuropathy.

The bill would also make some other changes, including removing a one-year residency requirement for those wanting to become patients, and altering a quarterly reporting requirement by physicians to a bi-yearly report. Another change is that it allows those from out-of-state to be covered by Georgia’s medical marijuana law for up to 45 days if they are a patient in their home state and have a condition that Georgia’s law covers.

Georgia House Passes Medical Marijuana Bill

March 1, 2017March 1, 2017

Georgia’s full House of Representatives has passed a bill that would significantly expand a medical marijuana law passed in 2015.

House Bill 65, sponsored by State Representative Allen Peake (R), was passed with an overwhelming 156 to 6 vote. The measure would expand a law passed in 2015 that allows for the medical use of low-THC cannabis medicines like tinctures and oils to include Alzheimer’s disease, autism, HIV/AIDS, autoimmune disease, Tourette’s syndrome epidermolysis bullosa and peripheral neuropathy as qualifying conditions.

The bill approved by the House would remove a one-year residency requirement for those wanting to become a medical cannabis patient. It would also allow those with medical cannabis cards from other states to legally possess and use the medicine in Georgia.

Georgia Governor Signs Medical Cannabis Bill into Law

May 4, 2015April 16, 2015

Georgia Governor Nathan Deal signing House Bill 1 into law.

To the sounds of thunderous applause, Governor Nathan Deal signed House Bill 1 into law Thursday, a proposal to legalize the medical use of cannabis extracts.

“For the families enduring separation and patients suffering pain, the wait is finally over,” said Governor Deal. “Now, Georgia children and their families may return home, while continuing to receive much-needed care. Patients such as Haleigh Cox, for whom this bill is named, and others suffering from debilitating conditions can now receive the treatment they need, in the place where they belong — Georgia.”

Georgia Governor Will Sign Bill Legalize Medical Use of Cannabis Extracts

March 26, 2015March 26, 2015

Georgia Governor Nathan Deal confirmed Thursday morning that he will soon sign into law legislation to legalize the medical use of cannabis extracts, which was recently approved overwhelmingly by the state’s Legislature.

House Bill 1, which was approved by the House of Representatives with an 160 to 1 vote, and by the Senate with a 48 to 6 vote, will legalize the possession and use of up to 20 ounces of low-THC (5% or less) cannabis extracts for those who receive a recommendation from a physician. Qualifying medical conditions will include cancer, Crohn’s disease, seizure disorders, Lou Gehrig’s disease (amyotrophic lateral sclerosis), mitochondrial disease, multiple sclerosis and Parkinson’s disease.

Georgia Legislature Passes Medical Cannabis Legislation, Sends it to Governor

March 25, 2015

Georgia’s House of Representatives voted 160 to 1 Wednesday to give final approval to House Bill 1, a proposal to legalize medical cannabis extracts that has already passed the full Senate. It now heads to Governor Nathan Deal for consideration, who is expected to sign the proposal as soon as Friday.

If signed into law by Governor Deal, or allowed to become law without his signature, House Bill 1 would allow those with cancer, Crohn’s disease, seizure disorders, Lou Gehrig’s disease (amyotrophic lateral sclerosis), mitochondrial disease, multiple sclerosis, Parkinson’s disease and sickle cell disease to possess and use up to 20 ounces of cannabis extracts. The extracts, which can include tinctures, oils, lotions and pills, would be required to have 5% THC or less, and patients must receive a recommendation from a physician.

Georgia Senate Approves Medical Cannabis Legalization Bill

March 24, 2015

A proposal to legalize the medical use of cannabis extracts such as tinctures and oils has been approved by Georgia’s full Senate, sending it to the state’s House which has already approved a slightly different version of the bill.

If approved into law, House Bill 1 would allow those with cancer, Crohn’s disease, Lou Gehrig’s disease (amyotrophic lateral sclerosis), mitochondrial disease, multiple sclerosis, Parkinson’s disease, seizure disorders and sickle cell disease to possess and use medical cannabis if they receive a recommendation from a physician. Patients would be allowed to possess up to 20 ounces of extracts, and the THC percentage of the medicine must not surpass 5%.